Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate …
… alternative treatment option. June 13, 2024 06:01 PM Eastern Daylight Time. INCHEON, South Korea–(BUSINESS WIRE)–Celltrion today presented …
… alternative treatment option. June 13, 2024 06:01 PM Eastern Daylight Time. INCHEON, South Korea–(BUSINESS WIRE)–Celltrion today presented …